Clinical Trial Update: Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of rabeprazole in infants with gastroesophageal reflux disease. The study is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2013-05-22